access the brazilian pharmaceutical market and be present
TRANSCRIPT
Access the Brazilian pharmaceutical market and
be present in the only Latin American Country
inserted in the BRICS!
The 11th BRICS Summit on November 13 and 14, 2019 in Brasilia - Brazil
presentation made by
LATAM MAP - GDP gross domestic product per Country LATAM MAP - GDP gross domestic product per Country
USD$ 19,7billion –6th of the world
67% of units sold and 34% of financial value are in Generics
1,7 thousand different active ingredients and associations
221 companies only
84% of revenues concentrated in only 53 companies
Fonte: 2018-2019 Anvisa CMED SAMMED Report / Interfarma Association
IN 2020 “40 REWARDING YEARS AND THE BEST IS YET TO COME”
“At our roots, we are an entrepreneurial family business, we are young adults of all ages, and we have the ambition to build better realities for the company, for our customers, for our partners, for our employees and for society.
We are repositioning NUNESFARMA with the exclusive NESH products developed at our own Research, Development and Innovation Center based in Curitiba, in the South of Brazil.
The learning journey is continuous. We always look for new projects and good partnerships. That is our Purpose!
Always attentive to the return. Inefficient spending and waste should not be repeated.
Together, we want to get there and achieve the established goal of expected results and gains for the projects. This is a cause to defend!
Lean, qualified team, with technology and intellectual capital as allies. Place where everyone delivers their results and has their merit recognized.
NUNESFARMA NESH: Health, Tradition and Innovation. At 40, the best is yet to come, and we want you together in this challenge!”
39+ years
we know how to make it happen in GMP Certifications and in Product Registration
with ANVISA
We have several success cases with Indian companies
We are an importer with all necessary licenses and
GMP certified good distribution and storage practices
We have qualified team and own technologies for the
development and insertion of new products in the Brazilian
pharmaceutical market
DOING BUSINESS
•Work with local Partners with same Values and Vision
•Encourage key executives to travel between India and Brazil
•Technology helps the distance
•Open and transparent, patient and perseverant
•Necessary a great channel of communication between owner-owner
•Commitment to make it happen is more important than the contract
Good News: Brazil and
Anvisa are
joining PICS
and ICH
“National Health Surveillance Agency”
No
Recent News from Regulatory framework
“The Nunesfarma's growth driver is to
develop new products with current and new Indian partners for the NESH portfolio”
Fernando Silva CEO
Thank you very much for your time!
Fernando Silva – CEO / Director
WhatsApp +55 (41) 99219 1116